Thermo Fisher Scientific SARS-CoV-2 Nucleocapsid Chimeric Recombinant Human Monoclonal Antibody (HC2003)

Applications

Tested Dilution

Publications

ELISA (ELISA)

0.1-10 µg/mL

-

Product Specifications

Host/Isotype

Human / IgG1

Expression System

proprietary

Class

Recombinant Monoclonal

Type

Antibody

Clone

HC2003

Immunogen

Recombinant SARS-CoV-2 Nucleocapsid Protein

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Storage conditions

-20°C

Shipping conditions

Wet ice

Product Specific Information

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is a most abundant structure protein of the coronavirus which is associated with nucleic acid.SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components.

Target Information

SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. The SARS-CoV-2 N protein is an abundant RNA-binding protein critical for viral genome packaging, yet the molecular details that involve this process are poorly understood. N protein contains three dynamic disordered regions that house putative transiently-helical binding motifs. The two folded domains interact minimally such that full-length N protein is a flexible and multivalent RNA-binding protein. SARS-CoV-2 causes illnesses ranging from the common cold to severe diseases.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.